Literature DB >> 16941380

Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.

David R Bangsberg1.   

Abstract

For antiretroviral therapy, the 95% adherence "threshold" is based on nucloside-exposed patients who are receiving partially suppressive, unboosted protease inhibitor regimens. Using unannounced pill counts and electronic medication monitoring, viral suppression is common with a 54%-100% mean adherence level to nonnucleoside reverse-transcriptase-inhibitor regimens. Although perfect adherence is an important goal, viral suppression is possible with moderate adherence to potent regimens.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16941380     DOI： 10.1086/507526

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  258 in total

1.  A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention.

Authors:  Daniel J Feaster; Victoria B Mitrani; Myron J Burns; Brian E McCabe; Ahnalee M Brincks; Allan E Rodriguez; Deshratn Asthana; Michael S Robbins
Journal:  Drug Alcohol Depend       Date:  2010-06-09       Impact factor: 4.492

2.  Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.

Authors:  Dean G Cruess; Seth C Kalichman; Christine Amaral; Connie Swetzes; Chauncey Cherry; Moira O Kalichman
Journal:  Ann Behav Med       Date:  2012-04

3.  Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.

Authors:  Alice Tseng; Michelle Foisy; Christine A Hughes; Deborah Kelly; Shanna Chan; Natalie Dayneka; Pierre Giguère; Niamh Higgins; Cara Hills-Nieminen; Jeff Kapler; Charles J L la Porte; Pam Nickel; Laura Park-Wyllie; Carlo Quaia; Linda Robinson; Nancy Sheehan; Shannon Stone; Linda Sulz; Deborah Yoong
Journal:  Can J Hosp Pharm       Date:  2012-03

4.  Situational temptation for HIV medication adherence in high-risk youth.

Authors:  Karen E Macdonell; Sylvie Naar-King; Debra A Murphy; Jeffrey T Parsons; Heather Huszti
Journal:  AIDS Patient Care STDS       Date:  2010-12-16       Impact factor: 5.078

5.  HIV-infected individuals who use alcohol and other drugs, and virologic suppression.

Authors:  Seonaid Nolan; Alexander Y Walley; Timothy C Heeren; Gregory J Patts; Alicia S Ventura; Meg M Sullivan; Jeffrey H Samet; Richard Saitz
Journal:  AIDS Care       Date:  2017-05-17

6.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

7.  The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV.

Authors:  Nikita Barai; Anne Monroe; Catherine Lesko; Bryan Lau; Heidi Hutton; Cui Yang; Anika Alvanzo; Mary Elizabeth McCaul; Geetanjali Chander
Journal:  AIDS Behav       Date:  2017-07

Review 8.  Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.

Authors:  Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell
Journal:  AIDS Behav       Date:  2014-04

9.  A Randomized Controlled Trial of Rise, a Community-Based Culturally Congruent Adherence Intervention for Black Americans Living with HIV.

Authors:  Laura M Bogart; Matt G Mutchler; Bryce McDavitt; David J Klein; William E Cunningham; Kathy J Goggin; Bonnie Ghosh-Dastidar; Nikki Rachal; Kelsey A Nogg; Glenn J Wagner
Journal:  Ann Behav Med       Date:  2017-12

10.  A Structural Equation Model of HIV-related Symptoms, Depressive Symptoms, and Medication Adherence.

Authors:  Moka Yoo-Jeong; Drenna Waldrop-Valverde; Katryna McCoy; Raymond L Ownby
Journal:  J HIV AIDS       Date:  2016-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.